The “a lot” came from the search results for “gates oxford covid patent” (I'd've expected people arguing against it if there was contention in opinion – this isn't the same as “it's fact”), though further investigation (the thing I didn't do; sorry) reveals that I only found two other articles: https://criticallegalthinking.com/2021/02/09/patent-capital-... and https://criticallegalthinking.com/2021/02/09/patent-capital-... the rest of the results are mirrors.
You're right that it's a rubbish thing to write; I'll put more effort into comments in future.
https://www.washingtonpost.com/washington-post-live/2021/02/...
MS. GATES: Well, we, along with many other partners, supported Oxford in saying what really needs to have happened there, they had incredible science, but they had never brought a vaccine to market. And so, they needed to partner with a pharmaceutical company who had expertise bringing a vaccine to market. And so, it was us and many partners that said that's a partnership that ought to happen. Ultimately, Oxford made that decision.